Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Long-Term Deferred Tax (2022 - 2023)

Spruce Biosciences (SPRB) has disclosed Long-Term Deferred Tax for 1 consecutive years, with $394000.0 as the latest value for Q4 2022.

  • On a quarterly basis, Long-Term Deferred Tax changed N/A to $394000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $394000.0, a N/A change, with the full-year FY2022 number at $394000.0, changed N/A from a year prior.
  • Long-Term Deferred Tax was $394000.0 for Q4 2022 at Spruce Biosciences.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $394000.0 in Q4 2022 to a low of $394000.0 in Q4 2022.